"Which Indicators Should Be Monitored When Administering Human Albumin Infusion?"

Infusion of Human Albumin: A Common Therapeutic Approach

The infusion of human albumin is a prevalent treatment method utilized to replenish bodily fluids and proteins. Prior to and subsequent to the infusion, physicians typically monitor various indicators to assess the therapeutic efficacy and patient's response. These common indicators encompass serum albumin concentration, plasma colloid osmotic pressure, coagulation function, liver function, and blood pressure, among others. Details are as follows:

1. Serum Albumin Concentration: Following albumin infusion, the serum albumin concentration rises, indicating an improvement in the patient's albumin levels.

2. Plasma Colloid Osmotic Pressure: Albumin serves as a plasma colloid, and its infusion enhances plasma osmotic pressure. Monitoring this pressure assesses the infusion's impact on fluid balance and osmotic pressure.

3. Coagulation Function: Albumin participates in the coagulation process. Post-infusion, coagulation function improves, aiding in hemorrhage control and thrombosis prevention.

4. Liver Function: Albumin is synthesized by the liver. Its infusion enhances liver function, facilitating the restoration of normal hepatic function.

5. Blood Pressure: Hypotension is a common side effect of albumin infusion. Thus, blood pressure changes must be monitored before and after infusion to ensure stability.

Additionally, urine output and nutritional status are also common indicators. Variations in these indicators guide physicians in adjusting treatment plans and ensuring patients receive safe and effective therapy. While albumin infusion is generally a relatively safe procedure, individual patients may experience allergies or allergic reactions to albumin. Should symptoms such as skin itching, rapid breathing, throat tightening, or facial swelling arise, immediately inform medical staff.